Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) — Form 4: Insider transaction
About this filing
Supernus Pharmaceuticals, Inc. (SUPN) filed Form 4 (insider transaction) with the SEC on Nov 2, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.
More SUPN filings
- 4
Filed Nov 2, 2026
- 4
Filed Nov 2, 2026
- 4
Filed Nov 2, 2026
- 4
Filed Nov 2, 2026
- 4
Filed Nov 2, 2026
- 8-K
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.